<p>In vivo bioluminescence imaging of transgene expression in FVB mice injected intravenously with rAAV-luciferase vectors harboring wild type capsid or capsids displaying a targeting peptide selected in the structural context of AAV2. Images were taken 28 days after vector injection, when whole animal bioluminescence intensities (BLI) reached peak values after injection of luciferase substrate. BLI ranges from 10<sup>5</sup>–10<sup>8</sup> relative light units per animal (photons/sec/cm<sup>2</sup>).</p
<p><b>Transfection efficiency and </b><b><i>in vivo</i></b><b> bioluminescence imaging.</b> (A) Expr...
none8Bioluminescence in vivo imaging (BLI) is a powerful tool in preclinical research allowing the r...
Effective development of therapeutics that target the molecular basis of disease is dependent on tes...
<p>Luciferase vectors derived from AAV2, -8 and -9 displaying breast cancer-directed peptides (ESGLS...
ii Michael Geusz, Advisor Bioluminescence imaging (BLI) of transgenic mice expressing the firefly lu...
<p>C57BL/6 mice were injected with 1×10e10 vg/animal of several most efficient mutant scAAV vectors ...
<p>(A) In vivo imaging assays of the three lines of transgenic mice (#1, #8 and #17). Transgenic mic...
<p>AAV luciferase vectors displaying selected peptides or controls (wild-type or VRRPRFW) were injec...
<p>Luciferase gene expression in various tissues was analyzed 28 days after intravenous injection of...
<p>A) Representative in vivo bioluminescence image of ASSCs transduced with different doses (1 and 0...
We have previously designed a library of lentiviral vectors to generate somatic-transgenic rodents t...
There has been a rapid growth of bioluminescence imaging applications in small animal models in rece...
<p>Normal mice were intravenously injected with leukemia cells (5×10<sup>5</sup>) that had been tran...
<p><i>In vivo</i> monitoring of luciferase activity at days 4, 9, 15 and 21 after the administration...
ABSTRACT Bioluminescent imaging (BLI) is a powerful noninvasive tool that has dramatically accelerat...
<p><b>Transfection efficiency and </b><b><i>in vivo</i></b><b> bioluminescence imaging.</b> (A) Expr...
none8Bioluminescence in vivo imaging (BLI) is a powerful tool in preclinical research allowing the r...
Effective development of therapeutics that target the molecular basis of disease is dependent on tes...
<p>Luciferase vectors derived from AAV2, -8 and -9 displaying breast cancer-directed peptides (ESGLS...
ii Michael Geusz, Advisor Bioluminescence imaging (BLI) of transgenic mice expressing the firefly lu...
<p>C57BL/6 mice were injected with 1×10e10 vg/animal of several most efficient mutant scAAV vectors ...
<p>(A) In vivo imaging assays of the three lines of transgenic mice (#1, #8 and #17). Transgenic mic...
<p>AAV luciferase vectors displaying selected peptides or controls (wild-type or VRRPRFW) were injec...
<p>Luciferase gene expression in various tissues was analyzed 28 days after intravenous injection of...
<p>A) Representative in vivo bioluminescence image of ASSCs transduced with different doses (1 and 0...
We have previously designed a library of lentiviral vectors to generate somatic-transgenic rodents t...
There has been a rapid growth of bioluminescence imaging applications in small animal models in rece...
<p>Normal mice were intravenously injected with leukemia cells (5×10<sup>5</sup>) that had been tran...
<p><i>In vivo</i> monitoring of luciferase activity at days 4, 9, 15 and 21 after the administration...
ABSTRACT Bioluminescent imaging (BLI) is a powerful noninvasive tool that has dramatically accelerat...
<p><b>Transfection efficiency and </b><b><i>in vivo</i></b><b> bioluminescence imaging.</b> (A) Expr...
none8Bioluminescence in vivo imaging (BLI) is a powerful tool in preclinical research allowing the r...
Effective development of therapeutics that target the molecular basis of disease is dependent on tes...